Phase 2 CAPTIVATE Study in CLL @SeattleCCA

Phase 2 CAPTIVATE Study in CLL @SeattleCCA

obr

3 months
1 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Chaitra Ujjani, MD, Associate Professor, @SeattleCCA University of Washington, Fred Hutchinson Cancer Research Center, offers her impression of the Phase 2 CAPTIVATE study investigating the BTK inhibitor ibrutinib plus venetoclax in the first-line treatment of chronic lymphocytic leukemia (CLL).
Up Next Autoplay